Not Yet RecruitingNot Applicable

Technology Assisted Treatment for Trichotillomania

90 participantsStarted 2026-03

Plain-language summary

The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. 18 years of age or older (criterion 1a) with a diagnosis of TTM focused on primary hair pulling location(s) above the neck (e.g., scalp, eyebrows, eye lashes, beard) (criterion 1b).
✓. English language fluency (criterion 2).
✓. Report no current pharmacological intervention targeting TTM symptoms OR a 6-week course of the intervention without change in dosage and intent for that dosage to remain stable for the 12 weeks of this trial (criterion 3a).
✓. Report no current psychosocial intervention targeting TTM (criterion 3b)

✕. Current suicidal/homicidal ideation, intent, or plan (criterion 1a) or a diagnosis of another psychiatric condition that may impede a participant's ability to fully utilize the app (e.g., psychotic disorder, eating disorder, moderate to severe major depressive disorder \[defined by meeting diagnostic criteria on the MINI and a score \>13 on DASS-21\]) (criterion 1b)
✕. Has not used HabitAware's Keen or Keen2 bracelet in the past 24 months.
✕. Residing outside the United States

Clinician-rated trichotillomania (TTM) symptom severity at endpoint (week 8)

Timeframe: Eight weeks

NCT IDNCT05118633

SponsorHabitAware Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-09

Sameer Kumar, BS